EUVIMEDEUVIMED entdecken
Open Access

Intestinal epithelium–derived IL-34 reprograms macrophages to mitigate gastrointestinal tract graft-versus-host disease

Aditya Rayasam iD, Alison Moe iD, Matthew Kudek iD, Ravi K Shah iD, Cheng-Yin Yuan iD, James M Miller iD, Mary Rau iD, Mollie Patton iD, Karolyn Wanat iD, Marco Colonna iD, Anthony E Zamora iD, William R Drobyski iD

Science Translational Medicine · 12.02.2025 · 17 (785)

DOI: 10.1126/scitranslmed.adn3963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 12.02.2025. Verfasst von Aditya Rayasam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Hauptthemen laut MEDLINE: Graft vs Host Disease, Interleukins, Intestinal Mucosa, Macrophages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal (GI) tract graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell transplantation and is attributable to dysregulation that occurs between the effector and regulatory arms of the immune system. Whereas regulatory T cells have a primary role in counterbalancing GVHD-induced inflammation, identifying and harnessing other pathways that promote immune tolerance remain major goals in this disease. Herein, we identified interleukin-34 (IL-34) as an intestinal epithelium–derived cytokine that was able to mitigate the severity of GVHD within the GI tract. Specifically, we observed that the absence of recipient IL-34 production exacerbated GVHD lethality, promoted intestinal epithelial cell death, and compromised barrier integrity. Mechanistically, the absence of host IL-34 skewed donor macrophages toward a proinflammatory phenotype and augmented the accumulation of pathogenic CD4 + granulocyte-macrophage colony-stimulating factor (GM-CSF) + T cells within the colon. Conversely, the administration of recombinant IL-34 substantially reduced GVHD mortality and inflammation, which was dependent on the expression of apolipoprotein E in donor macrophages. Complementary genetic and imaging approaches in mice demonstrated that intestinal epithelial cells were the relevant source of IL-34. These results were supported by colonic biopsies from patients with GVHD, which displayed IL-34 expression in intestinal epithelial cells and apolipoprotein E in lamina propria macrophages, validating similar cellular localization in humans. These studies indicate that IL-34 acts as a tissue-intrinsic cytokine that regulates GVHD severity in the GI tract and could serve as a potential therapeutic target for amelioration of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseInterleukinsIntestinal MucosaMacrophagesGastrointestinal TractAnimalsMice, Inbred C57BLMiceHumansHematopoietic Stem Cell TransplantationInflammation

Substanzen

Interleukinsinterleukin-34, mouse

Autor:innen und Institutionen

  • Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Department of Pathology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Department of Pathology and Immunology, Washington University, Saint Louis, MO 63110, USA.
  • Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

ORCID-Profile: Aditya Rayasam, Alison Moe, Matthew Kudek, Ravi K Shah, Cheng-Yin Yuan, James M Miller, Mary Rau, Mollie Patton, Karolyn Wanat, Marco Colonna, Anthony E Zamora, William R Drobyski

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Rayasam, A., Moe, A., Kudek, M., Shah, R. K., Yuan, C. Y., Miller, J. M., Rau, M., Patton, M., Wanat, K., Colonna, M., Zamora, A. E., & Drobyski, W. R. (2025). Intestinal epithelium–derived IL-34 reprograms macrophages to mitigate gastrointestinal tract graft-versus-host disease. Science Translational Medicine, 17(785). https://doi.org/10.1126/scitranslmed.adn3963

Vancouver

Rayasam A, Moe A, Kudek M, Shah RK, Yuan CY, Miller JM, et al. Intestinal epithelium–derived IL-34 reprograms macrophages to mitigate gastrointestinal tract graft-versus-host disease. Science Translational Medicine. 2025;17(785). doi:10.1126/scitranslmed.adn3963

BibTeX
@article{Rayasam2025,
  author = {Rayasam, Aditya and Moe, Alison and Kudek, Matthew and Shah, Ravi K and Yuan, Cheng-Yin and Miller, James M and Rau, Mary and Patton, Mollie and Wanat, Karolyn and Colonna, Marco and Zamora, Anthony E and Drobyski, William R},
  title = {Intestinal epithelium–derived IL-34 reprograms macrophages to mitigate gastrointestinal tract graft-versus-host disease},
  journal = {Science Translational Medicine},
  year = {2025},
  volume = {17},
  number = {785},
  doi = {10.1126/scitranslmed.adn3963}
}
Kostenlos starten →